Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Tuberculosis and HIV news

Show

From To
New and better drugs for MDR-TB on the horizon

A phase III trial of a novel combination of drugs for tuberculosis, including some drug-resistant strains, will launch within the year, the TB Alliance announced.

Published
16 hours ago
From
The Guardian
South Africa: ARV Programme Saves 780 000 Lives

South Africa's HIV antiretroviral treatment programme saved 780 000 lives between 2003 and 2012, according to a recently released independent review. But the tuberculosis programme is failing to meet targets.

Published
14 April 2014
From
Health-e
Big Pharma Abandons New Tuberculosis Drug Research

Three major pharmaceutical companies - AstraZeneca, Johnson & Johnson and Pfizer - have recently delayed or canceled clinical trials for testing tuberculosis (TB) drugs in India and South Africa. Activists say this is symbolic of a trend by Big Pharma to abandon research into diseases that affect poor people.

Published
02 April 2014
From
CorpWatch.org
Mass TB Tests 'Would Save Billions'

A World Bank study has estimated that South Africa, Lesotho, Swaziland, and Mozambique could save approximately 13 billion rand a year in increased productivity and reduced TB transmission by spending 330 million rand per year to test and treat miners in the gold and platinum mining industry for TB.

Published
31 March 2014
From
Business Daily
Announcement: Updated Guidelines on Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis

The updated guidelines include recommendations for use of newer antiretroviral drugs, including those in new classes, such as CCR5 receptor antagonists and integrase inhibitors. The new guidelines provide additional recommendations regarding use of rifampin with antiretroviral therapy; these recommendations are critical in regions where rifabutin is unavailable.

Published
31 March 2014
From
Morbidity and Mortality Weekly Report
New consensus reached to help tackle multidrug-resistant and extensively drug-resistant TB

New consensus statements have been developed to help tackle the growing threat of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis.

Published
26 March 2014
From
Eurekalert Medicine & Health
Flatlined: U.S. Government Investments in Tuberculosis Research and Development, 2009–2012

There were only 9,951 new domestic cases of TB in 2012, the lowest level since reporting began in 1953.2 Yet falling funding for TB research threatens to roll back the hard-won achievements of the last two decades.

Published
24 March 2014
From
Treatment Action Group
Combating Tuberculosis: special report

Tuberculosis remains one of the greatest public health risks in many low- and middle-income countries, while the emergence of deadly new drug-resistant strains of TB threatens to unravel years of progress.

Published
24 March 2014
From
Financial Times
New Study Shows Smoking Tobacco Doubles Risk of Recurrent Tuberculosis

The study is the most robust ever conducted into how smoking tobacco increases the risk of recurrent TB. It appears in the April issue of the International Journal of Tuberculosis and Lung Disease.Regular tobacco smokers were defined as individuals who smoked 10 or more cigarettes—equivalent to half a pack—per day.

Published
24 March 2014
From
International Union Against Tuberculosis and Lung Disease
Poor Diagnosis Driving Global Multidrug-Resistant TB, WHO Warns

In 2012, fewer than 25 percent of the 500,000 people with multidrug-resistant TB (MDR TB) infections received a diagnosis, according to the World Health Organization (WHO). As a result, many MDR TB-infected individuals received the wrong treatment or no treatment at all.

Published
24 March 2014
From
Reuters
← First12345...81Next →

Filter by country